A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)
Phase 2
Recruiting
- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
- Interventions
- First Posted Date
- 2022-07-25
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Belgian Group of Digestive Oncology
- Target Recruit Count
- 134
- Registration Number
- NCT05472259
- Locations
- 🇧🇪
AZ St-Lucas, Brugge, West-Vlaanderen, Belgium
🇧🇪UZ Antwerpen, Antwerp, Belgium
🇧🇪AZ Imelda, Bonheiden, Belgium
A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma
Phase 3
Active, not recruiting
- Conditions
- Small Bowel Adenocarcinoma
- Interventions
- Drug: Fluoropyrimidine
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Belgian Group of Digestive Oncology
- Target Recruit Count
- 30
- Registration Number
- NCT04257461
- Locations
- 🇧🇪
AZ Turnhout, Turnhout, Antwerpen, Belgium
🇧🇪Onze-Lieve-Vrouw Ziekenhuis Aalst, Aalst, Oost-Vlaanderen, Belgium
🇧🇪AZ St-Lucas, Gent, Oost-Vlaanderen, Belgium
© Copyright 2025. All Rights Reserved by MedPath